EU TRANSPARENCY REGISTER · 232923831740-31 · Sweden

Swedish Orphan Biovitrum

Sobi

Category

Companies & groups

Country

Sweden

Stockholm

Entity form

AB

Stated objectives

Sobi is a global biopharmaceutical company specialized in rare diseases developing and providing access to innovative treatments in the areas of haematology, immunology and specialty care. Sobi offers an integrated process, from in-house re…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2018-06-07

Last updated

2026-04-24

Other Companies & groups in Sweden

Other registered organisations in Sweden

Frequently asked questions

What is this organisation?
Swedish Orphan Biovitrum (Sobi) is an interest representative listed in the EU Joint Transparency Register under ID 232923831740-31. Entity form: AB.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Sweden, Stockholm.
What are its stated goals?
As declared by the registrant: Sobi is a global biopharmaceutical company specialized in rare diseases developing and providing access to innovative treatments in the areas of haematology, immunology and specialty care. Sobi offers an integrated process, from in-house re…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 232923831740-31.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-11 · Commission Reuse Decision 2011/833/EU